Abstract
Prostatic cancer is the most common non-cutaneous malignancy in men and the second leading cause of cancer-related mortality. Present study was planned to evaluate the F-18 PSMA-PET/CT-guided biopsy from a PSMA-expressing prostatic lesion through the trans-gluteal approach to avoid rectal penetration.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
